medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2014, Number 609

<< Back Next >>

Rev Med Cos Cen 2014; 71 (609)

Disfunción eréctil y su relación con el síndrome metabólico

Quesada AP

Language: Spanish
References: 16
Page: 135-140
PDF size: 173.48 Kb.


ABSTRACT

Objective: To determine the implication of metabolic syndrome in relation to patients with erectile dysfunction.
Method: A comprehensive literature spanned the latest updates related to metabolic syndrome and erectile dysfunction.
Results: The metabolic syndrome is a clinical condition issue that seems to be caused by a combination of genetic predisposition and factors related to lifestyle, especially obesity (excess) and inactivity. Excess body fat (especially abdominal) and physical inactivity promote the development of insulin resistance in genetically predisposed individuals. Metabolic syndrome is associated with decreased survival, particularly due to increased cardiovascular mortality. From a viewpoint uroandrological, interest is due to its association with erectile dysfunction (ED) and androgen deficiency or hypogonadism. Hypertension, hypercholesterolemia, insulin resistance and obesity are cardiovascular risk factors are highly prevalent and often associated with hypogonadism (low testosterone). The possible consequences of this combination can be fatal.
Conclusions: Articles show that erectile dysfunction in men from 35 to 50 years preceding it in 4 or 5 years the cardiovascular problem; this is an important point for the doctor, because the trend of non-specialist is considered that erectile dysfunction is a problem quality of life and not a precesor cardiovascular disease.


REFERENCES

  1. Álvarez EE, Ribas L, Serra L. Prevalencia del síndrome metabólico en la población de la Comunidad Canaria. Med Clin (Barc). 2003;120:172-4.

  2. Alegría E, Cordero A, Grima A, Casasnovas JA, Laclaustra M, Luengo E, et al.. Prevalencia del síndrome 140 REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA metabólico en población laboral española: Registro MESYAS. Rev Esp Cardiol. 2005;58:797-806.

  3. Ai A, Tanaka A, Ogita K, Sekine M, Numano F, Numano U, Reaven G. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrinol Metabol 2000; 85:3557- 60.

  4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM.. NECPDefined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-4.

  5. Alberti, K., Eckel, R., Grundy, S. et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Athero-sclerosis Society, and International Association for the Study of Obesity. Circulation 2009, 120: 1640-5.

  6. Cordero A, Alegría E, León M. Prevalencia del síndrome metabólico. Rev Esp Cardiol. 2006;5:11-15.

  7. Cameron, A.J., Magliano, D.J., Zimmet, P.Z., Welborn, T.A., Colagiuri, S., Tonkin, A.M., Shaw, J.E. The metabolic syndrome as a tool for predicting future diabetes:The Aus Diab study. J Intern Med 2008, 264(2): 177-86.

  8. Gimeno JA, Lou JM, Molinero E, Poned B, Portilla DP. Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2. Rev Esp Cardiol 2004;57:507-13.

  9. Remigio Vela Navarrete, MONOGRÁFICO: DISFUNCIÓN ERÉCTIL;. Arch. Esp. Urol. vol.63 no.8 Madrid oct. 2010.

  10. Reaven, G. Role of insulin resistance in human disease. Diabetes 1988, 37: 1595-607. 2. Zavaroni, I., Bonora, E., Pagliara, M. et al. Risk factors for coronary artery disease in healthy persons with hypersinulinemia and normal glucose tolerance. N Engl J Med 1989, 320: 702-6.

  11. Reilly MP, Rader DJ.. The metabolic syndrome: more than the sum of it’s parts? Circulation. 2003;108:1546-51.

  12. Serrano Ríos, M. Síndrome metabólico. Tiempos médicos 2009 66 245-48 .

  13. Simmons, R.K., Alberti, M., Gale, M. et al. The metabolic syndrome: Useful concept or clinical tool?. Report of a WHO Expert Consultation. Diabetologia 2010, 53: 600-5.

  14. Schillaci, G., Pirro, M., Vaudo, G., Gemelli F, Marchesi S, Porcellati E, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004, 43: 1817-22.

  15. WHO consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. WHO/ NCD/NCS/1999.2; 31-3.

  16. Yassin, A.A.; Saad, F.; Gooren, L.J. Methabolic syndrome, testosterone deficiency and erectile disfunction never come alone. Andrología 2008 40;4;259-264.




2020     |     www.medigraphic.com